Skip to main content
. 2022 Apr;13(2):478–487. doi: 10.21037/jgo-22-131

Table 4. Pathological results in patients receiving neoadjuvant immunotherapy and chemotherapy plus surgery.

Content Number (%)
Pathology response in tumor
   1 2 (16.7)
   2 3 (25.0)
   3 6 (50.0)
   4 1 (8.3)
Pathological stage
   I 4 (33.3)
   II 1 (8.3)
   IIIA 1 (8.3)
   IIIB 6 (50.0)
   IVA 0
Nerve invasion 3 (25.0)
Vascular invasion 4 (33.3)
Lymphatic metastasis 7 (58.3)
Thoracic lymphatic metastasis 6 (50.0)
Abdominal lymphatic metastasis 2 (16.7)